Background
Radial scars (RS) or complex sclerosing lesions (CSL) of the breast are benign radiological and histological entities. Radiologically, they appear as architectural distortion with central radiolucency. These stellate lesions are frequently identified on screening mammography and, with the introduction of population-based screening programs; their incidence has increased to 0.03%–0.09% of all core needle biopsies (CNB). However, they can pose diagnostic difficulty as their radiologic and histologic appearance mimic carcinoma. Because of the high incidence of atypia or associated occult malignancy, the current literature recommendation is excision of all mammographically detected RS/CSL diagnosed on CNB.
Aims and Objective
Our aim was to review all RS/CSL that were previously diagnosed on image-guided CNB from January 1st, 1994 to August 31st, 2013, and assess the pathology from the excisional biopsy to identify cases upstaged to atypia or neoplasm.
Results
There were a total of 113 CNB from 109 women with radial scar without concomitant atypia on CNB diagnosed during that period; five cases were excluded because of concurrent cancer. Average age of these women was 52.9 years (range: 23.0 – 82.0 years). Thirty-five women (38/100 CNB; 38.0%) have follow-up excision. The median size of the excised radial scars is 1.2 cm (range: 0.4 – 3.3 cm). More than two-thirds of excised cases (68.6%; 24/35) were greater than 1.0 cm. The mammographic and ultrasonographic imaging features were listed as architectural distortion in 53.1% (17/32) and hypoechoic nodules with irregular margins in 36.4% (12/33) respectively. Almost all excised cases 91.7%; 33/36) showed radiologic and pathologic concordance, and more than three-quarters (23/29; 79.3%) are designated as Bi-Rads level 4 (suspicious for malignancy). The 38 follow-up excisional biopsies revealed: 2 (5.3%) invasive mammary carcinomas (2 metaplastic carcinomas including adenoid cystic carcinoma); 2 (5.3%) in-situ ductal carcinoma; 1 (2.6%) lobular carcinoma in-situ; 5 (13.2%) atypical lobular hyperplasia; 1 (2.6%) atypical ductal hyperplasia; 22 (57.9%) residual radial scars; and 5 (13.2%) with no residual lesions on follow-up.
Conclusion
Follow-up excisional biopsy is warranted for RS/CSL specifically if they are larger than 1.0 cm with worrisome radiographic images or showed radiologic and pathologic discordance, as approximately 29% (11/38) of these cases will have an upgrade to in-situ or invasive carcinomas or other high risk lesions on follow-up.